DAVIDE CAMPARI-MILANO NV (CPR.MI) Stock Fundamental Analysis

Europe • Euronext Milan • BIT:CPR • NL0015435975

6.32 EUR
-0.02 (-0.35%)
Last: Feb 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CPR. CPR was compared to 28 industry peers in the Beverages industry. CPR has an average financial health and profitability rating. While showing a medium growth rate, CPR is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year CPR was profitable.
  • In the past year CPR had a positive cash flow from operations.
  • In the past 5 years CPR has always been profitable.
  • CPR had a positive operating cash flow in each of the past 5 years.
CPR.MI Yearly Net Income VS EBIT VS OCF VS FCFCPR.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 2.51%, CPR is doing worse than 64.29% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 5.44%, CPR is doing worse than 67.86% of the companies in the same industry.
  • CPR has a Return On Invested Capital (7.03%) which is in line with its industry peers.
  • CPR had an Average Return On Invested Capital over the past 3 years of 7.66%. This is in line with the industry average of 7.85%.
Industry RankSector Rank
ROA 2.51%
ROE 5.44%
ROIC 7.03%
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
CPR.MI Yearly ROA, ROE, ROICCPR.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 6.57%, CPR is in line with its industry, outperforming 42.86% of the companies in the same industry.
  • CPR's Profit Margin has declined in the last couple of years.
  • Looking at the Operating Margin, with a value of 21.32%, CPR is in the better half of the industry, outperforming 64.29% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CPR has remained more or less at the same level.
  • CPR has a Gross Margin of 57.55%. This is in the better half of the industry: CPR outperforms 78.57% of its industry peers.
  • In the last couple of years the Gross Margin of CPR has remained more or less at the same level.
Industry RankSector Rank
OM 21.32%
PM (TTM) 6.57%
GM 57.55%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
CPR.MI Yearly Profit, Operating, Gross MarginsCPR.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • CPR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • CPR has more shares outstanding than it did 1 year ago.
  • CPR has more shares outstanding than it did 5 years ago.
  • CPR has about the same debt/assets ratio as last year.
CPR.MI Yearly Shares OutstandingCPR.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
CPR.MI Yearly Total Debt VS Total AssetsCPR.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • CPR has an Altman-Z score of 2.66. This is not the best score and indicates that CPR is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.66, CPR is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
  • The Debt to FCF ratio of CPR is 8.49, which is on the high side as it means it would take CPR, 8.49 years of fcf income to pay off all of its debts.
  • CPR has a Debt to FCF ratio (8.49) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.64 indicates that CPR is somewhat dependend on debt financing.
  • CPR has a better Debt to Equity ratio (0.64) than 71.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 8.49
Altman-Z 2.66
ROIC/WACC1.03
WACC6.83%
CPR.MI Yearly LT Debt VS Equity VS FCFCPR.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 2.32 indicates that CPR has no problem at all paying its short term obligations.
  • CPR has a better Current ratio (2.32) than 89.29% of its industry peers.
  • CPR has a Quick Ratio of 2.32. This is a bad value and indicates that CPR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CPR has a better Quick ratio (0.91) than 82.14% of its industry peers.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 0.91
CPR.MI Yearly Current Assets VS Current LiabilitesCPR.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for CPR have decreased strongly by -40.50% in the last year.
  • The Earnings Per Share has been decreasing by -8.12% on average over the past years.
  • CPR shows a small growth in Revenue. In the last year, the Revenue has grown by 5.18%.
  • CPR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.75% yearly.
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-8.36%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%0.3%

3.2 Future

  • CPR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.51% yearly.
  • Based on estimates for the next years, CPR will show a small growth in Revenue. The Revenue will grow by 4.25% on average per year.
EPS Next Y2.19%
EPS Next 2Y4.77%
EPS Next 3Y7.34%
EPS Next 5Y11.51%
Revenue Next Year1.47%
Revenue Next 2Y1.82%
Revenue Next 3Y2.95%
Revenue Next 5Y4.25%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CPR.MI Yearly Revenue VS EstimatesCPR.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
CPR.MI Yearly EPS VS EstimatesCPR.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 37.18, CPR can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Earnings ratio of CPR indicates a slightly more expensive valuation: CPR is more expensive than 78.57% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.92. CPR is valued slightly more expensive when compared to this.
  • A Price/Forward Earnings ratio of 19.39 indicates a rather expensive valuation of CPR.
  • Based on the Price/Forward Earnings ratio, CPR is valued a bit more expensive than 64.29% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CPR to the average of the S&P500 Index (27.78), we can say CPR is valued slightly cheaper.
Industry RankSector Rank
PE 37.18
Fwd PE 19.39
CPR.MI Price Earnings VS Forward Price EarningsCPR.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CPR is valued a bit more expensive than 60.71% of the companies in the same industry.
  • 64.29% of the companies in the same industry are cheaper than CPR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 24.25
EV/EBITDA 12.57
CPR.MI Per share dataCPR.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)17
PEG (5Y)N/A
EPS Next 2Y4.77%
EPS Next 3Y7.34%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

2

5. Dividend

5.1 Amount

  • CPR has a Yearly Dividend Yield of 1.12%.
  • Compared to an average industry Dividend Yield of 2.77, CPR is paying slightly less dividend.
  • CPR's Dividend Yield is slightly below the S&P500 average, which is at 1.83.
Industry RankSector Rank
Dividend Yield 1.12%

5.2 History

  • The dividend of CPR decreases each year by -2.80%.
Dividend Growth(5Y)-2.8%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 38.69% of the earnings are spent on dividend by CPR. This is a low number and sustainable payout ratio.
DP38.69%
EPS Next 2Y4.77%
EPS Next 3Y7.34%
CPR.MI Yearly Income VS Free CF VS DividendCPR.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
CPR.MI Dividend Payout.CPR.MI Dividend Payout, showing the Payout Ratio.CPR.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

DAVIDE CAMPARI-MILANO NV

BIT:CPR (2/6/2026, 7:00:00 PM)

6.32

-0.02 (-0.35%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)10-29
Earnings (Next)02-24
Inst Owners23.2%
Inst Owner ChangeN/A
Ins Owners50.8%
Ins Owner ChangeN/A
Market Cap7.78B
Revenue(TTM)3.07B
Net Income(TTM)201.60M
Analysts72.31
Price Target7.05 (11.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.12%
Yearly Dividend0.04
Dividend Growth(5Y)-2.8%
DP38.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.07%
PT rev (3m)2.37%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.16%
EPS NY rev (3m)2.95%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.83%
Valuation
Industry RankSector Rank
PE 37.18
Fwd PE 19.39
P/S 2.53
P/FCF 24.25
P/OCF 11.93
P/B 2.1
P/tB 64.1
EV/EBITDA 12.57
EPS(TTM)0.17
EY2.69%
EPS(NY)0.33
Fwd EY5.16%
FCF(TTM)0.26
FCFY4.12%
OCF(TTM)0.53
OCFY8.38%
SpS2.49
BVpS3.01
TBVpS0.1
PEG (NY)17
PEG (5Y)N/A
Graham Number3.39
Profitability
Industry RankSector Rank
ROA 2.51%
ROE 5.44%
ROCE 9.58%
ROIC 7.03%
ROICexc 7.57%
ROICexgc 17.42%
OM 21.32%
PM (TTM) 6.57%
GM 57.55%
FCFM 10.45%
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
ROICexc(3y)8.52%
ROICexc(5y)8.34%
ROICexgc(3y)23.37%
ROICexgc(5y)25.9%
ROCE(3y)10.45%
ROCE(5y)9.91%
ROICexgc growth 3Y-20.45%
ROICexgc growth 5Y-21.73%
ROICexc growth 3Y-7.67%
ROICexc growth 5Y-5.91%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 8.49
Debt/EBITDA 2.97
Cap/Depr 230.39%
Cap/Sales 10.79%
Interest Coverage 6.41
Cash Conversion 81.69%
Profit Quality 159.18%
Current Ratio 2.32
Quick Ratio 0.91
Altman-Z 2.66
F-Score6
WACC6.83%
ROIC/WACC1.03
Cap/Depr(3y)346.34%
Cap/Depr(5y)266.11%
Cap/Sales(3y)12.99%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%-8.36%
EPS Next Y2.19%
EPS Next 2Y4.77%
EPS Next 3Y7.34%
EPS Next 5Y11.51%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%0.3%
Revenue Next Year1.47%
Revenue Next 2Y1.82%
Revenue Next 3Y2.95%
Revenue Next 5Y4.25%
EBIT growth 1Y6.42%
EBIT growth 3Y15.63%
EBIT growth 5Y10.27%
EBIT Next Year26.24%
EBIT Next 3Y12.26%
EBIT Next 5Y10.28%
FCF growth 1Y290.11%
FCF growth 3Y-14.61%
FCF growth 5Y-4.94%
OCF growth 1Y205.34%
OCF growth 3Y11.5%
OCF growth 5Y13.06%

DAVIDE CAMPARI-MILANO NV / CPR.MI FAQ

Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?

ChartMill assigns a fundamental rating of 4 / 10 to CPR.MI.


What is the valuation status for CPR stock?

ChartMill assigns a valuation rating of 1 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.


What is the profitability of CPR stock?

DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 4 / 10.


Can you provide the financial health for CPR stock?

The financial health rating of DAVIDE CAMPARI-MILANO NV (CPR.MI) is 5 / 10.


Can you provide the expected EPS growth for CPR stock?

The Earnings per Share (EPS) of DAVIDE CAMPARI-MILANO NV (CPR.MI) is expected to grow by 2.19% in the next year.